X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
X4 Pharmaceuticals (Nasdaq: XFOR) announced that its management team will participate in the Guggenheim Second Annual Healthcare Innovation Conference in Boston on November 10–12, 2025. The company will host a fireside chat on November 10 at 8:30 a.m. ET and will be available for one-on-one investor meetings. A live webcast of the fireside chat will be available on the company’s Investors > Events and Presentations page, with a replay accessible for 30 days after the event. For more information, visit investors.x4pharma.com.
X4 Pharmaceuticals (Nasdaq: XFOR) ha annunciato che il suo team dirigenziale parteciperà alla Guggenheim Second Annual Healthcare Innovation Conference a Boston dal 10 al 12 novembre 2025. L'azienda ospiterà una chiacchierata informale il 10 novembre alle 8:30 ora ET e sarà disponibile per incontri individuali con gli investitori. Una trasmissione in live webcast della chiacchierata informale sarà disponibile sulla pagina Investors > Events and Presentations dell'azienda, con una replica accessibile per 30 giorni dopo l'evento. Per ulteriori informazioni, visitare investors.x4pharma.com.
X4 Pharmaceuticals (Nasdaq: XFOR) anunció que su equipo de dirección participará en la Conferencia de Innovación en Salud Guggenheim Segunda Anual en Boston del 10 al 12 de noviembre de 2025. La empresa organizará una charla informal (fireside chat) el 10 de noviembre a las 8:30 a.m. hora ET y estará disponible para reuniones individuales con inversores. Una transmisión en vivo de la charla estará disponible en la página de la empresa Investors > Events and Presentations, y se podrá ver la repetición durante 30 días después del evento. Para más información, visite investors.x4pharma.com.
X4 Pharmaceuticals (나스닥: XFOR)은 경영진이 보스턴에서 열리는 Guggenheim 제2회 연례 헬스케어 혁신 컨퍼런스에 참가할 것이라고 발표했습니다. 일정은 2025년 11월 10–12일입니다. 회사는 11월 10일 동부 표준시 8:30에 개최되는 파이어사이드 채팅을 주최하며 투자자들과의 일대일 면담도 가능합니다. 파이어사이드 채팅의 라이브 웹캐스트는 회사의 Investors > Events and Presentations 페이지에서 시청 가능하며 이벤트 후 30일 동안 다시 보기를 이용할 수 있습니다. 자세한 내용은 investors.x4pharma.com를 참조하십시오.
X4 Pharmaceuticals (Nasdaq: XFOR) a annoncé que son équipe de direction participera à la Conférence Guggenheim sur l'Innovation dans les Soins de Santé, deuxième édition à Boston du 10 au 12 novembre 2025. L'entreprise accueillera une conversation informelle (fireside chat) le 10 novembre à 8h30 HE et sera disponible pour des entretiens individuels avec les investisseurs. Une diffusion en direct de la conversation sera disponible sur la page Investors > Events and Presentations de l'entreprise, avec une réplique accessible pendant 30 jours après l'événement. Pour plus d'informations, visitez investors.x4pharma.com.
X4 Pharmaceuticals (Nasdaq: XFOR) gab bekannt, dass das Management-Team am Guggenheim Second Annual Healthcare Innovation Conference in Boston teilnehmen wird vom 10. bis 12. November 2025. Das Unternehmen wird am 10. November um 8:30 Uhr MEZ eine fireside chat veranstalten und steht für persönliche Investorengespräche zur Verfügung. Eine Live-Übertragung der Fireside-Chat wird auf der Seite des Unternehmens Investors > Events and Presentations verfügbar sein, eine Wiedergabe ist 30 Tage nach der Veranstaltung zugänglich. Weitere Informationen finden Sie unter investors.x4pharma.com.
X4 Pharmaceuticals (Nasdaq: XFOR) أعلنت أن فريقها الإداري سيشارك في مؤتمر Guggenheim الثاني للابتكار في الرعاية الصحية في بوسطن خلال الفترة من 10–12 نوفمبر 2025. ستستضيف الشركة محادثة حوارية غير رسمية (fireside chat) في 10 نوفمبر الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة وستكون متاحة للاجتماعات الثنائية مع المستثمرين. سيكون البث المباشر للمحادثة متاحاً على صفحة Investors > Events and Presentations التابعة للشركة، مع إمكانية مشاهدة إعادة البث لمدة 30 يوماً بعد الحدث. للمزيد من المعلومات، يرجى زيارة investors.x4pharma.com.
- None.
- None.
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today announced that the management team will participate in the upcoming Guggenheim Second Annual Healthcare Innovation Conference on November 10-12, 2025 in Boston.
The X4 team will hold a fireside chat on November 10th at 8:30 a.m. ET and will be available for one-on-one meetings with investors.
A webcast of the fireside chat will be available under the “Events and Presentations” page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit investors.x4pharma.com.
About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare hematology diseases and significant unmet needs. Leveraging expertise in CXCR4, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is currently being marketed in the U.S. as XOLREMDI® in its first indication. The company is also evaluating additional uses of mavorixafor and is conducting a global, pivotal Phase 3 clinical trial (4WARD) in patients with certain chronic neutropenic disorders. X4 is headquartered in Boston, Massachusetts. For more information, please visit www.x4pharma.com.
X4 Investor Contact:
IR@X4pharma.com
FAQ
When will X4 Pharmaceuticals (XFOR) present at the Guggenheim Healthcare Innovation Conference?
How can investors watch X4 Pharmaceuticals (XFOR) fireside chat on November 10, 2025?
Will X4 Pharmaceuticals (XFOR) offer a replay of the Guggenheim conference webcast?
Can investors request one-on-one meetings with X4 Pharmaceuticals (XFOR) at the conference?
Where can I find more information about X4 Pharmaceuticals (XFOR) conference participation?
